Merck比收入估计数高,但错过了收入;重申了2025年的前景。 Merck beats earnings estimates but misses revenue; reaffirms 2025 outlook.

Merck & Co.公司报告说,第二季度的收益为每股2.13美元,估计增加0.10美元,尽管收入为158.1亿美元,略微超出预期。 Merck & Co. reported second-quarter earnings of $2.13 per share, beating estimates by $0.10, though revenue of $15.81 billion slightly missed expectations. 该公司重申其2025年收入准则,即每股8.87至8.97美元,分析师预测为9.01美元。 The company reaffirmed its 2025 earnings guidance at $8.87–8.97 per share, with analysts projecting $9.01. 机构所有制占76.07%。 Institutional ownership stands at 76.07%. John G Ullman & Associates公司股份增加了0.4%,而Forvis Mazars公司股份减少了1.0%。 John G Ullman & Associates increased its stake by 0.4%, while Forvis Mazars reduced its holding by 1.0%. 股票交易额为84.78美元,市场上限为211.76亿美元,P/E比率为13.06,红利收益为3.8%。 The stock, trading at $84.78, has a market cap of $211.76 billion, a P/E ratio of 13.06, and a dividend yield of 3.8%. 分析员维持协商一致的“等待”评级,目标为104.33美元。 Analysts maintain a consensus "Hold" rating with a target of $104.33.